NCT06622915 Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic Syndrome
| NCT ID | NCT06622915 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Nephrotic Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2025-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-07-15 with a primary completion date of 2025-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
nephrotic syndrome (NS) is one of the most common pediatric kidney diseases There is an increased incidence of heart disease in patients with primary nephrotic syndrome (PNS) compared to the normal population Conventional Echocardiography is usually utilized to diagnose myocardial dysfunction. Tissue Doppler imaging is a non-invasive cardiac imaging technique which measures the velocity of the longitudinal motion of the mitral annulus, tricuspid annulus and the basal part of interventricular septum
Eligibility Criteria
Inclusion Criteria: * Children with primary nephrotic syndrome. * Age: 2 - 14 years. * Both males and females Exclusion Criteria: * Patients of primary cardiac diseases (e.g., congenital or rheumatic heart disease, cardio- myopathy). Patients who refuse to give written informed consent to study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06622915 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 14 Years, studying Nephrotic Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06622915 currently recruiting?
Yes, NCT06622915 is actively recruiting participants. Contact the research team at alaa.yehya@med.sohag.edu.eg for enrollment information.
Where is the NCT06622915 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT06622915 clinical trial?
NCT06622915 is sponsored by Sohag University. The trial plans to enroll 60 participants.